Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study

Jeffrey S. Hyams, Sonia Davis Thomas, Nathan Gotman, Yael Haberman, Rebekah Karns, Melanie Schirmer, Angela Mo, David R. Mack, Brendan Boyle, Anne M. Griffiths, Neal S. LeLeiko, Cary G. Sauer, David J. Keljo, James Markowitz, Susan S. Baker, Joel Rosh, Robert N. Baldassano, Ashish Patel, Marian Pfefferkorn, Anthony OtleyMelvin Heyman, Joshua Noe, Maria Oliva-Hemker, Paul A. Rufo, Jennifer Strople, David Ziring, Stephen L. Guthery, Boris Sudel, Keith Benkov, Prateek Wali, Dedrick Moulton, Jonathan Evans, Michael D. Kappelman, M. Alison Marquis, Francisco A. Sylvester, Margaret H. Collins, Suresh Venkateswaran, Marla Dubinsky, Vin Tangpricha, Krista L. Spada, Bradley Saul, Jessie Wang, Jose Serrano, Kevin Hommel, Urko M. Marigorta, Greg Gibson, Ramnik J. Xavier, Subra Kugathasan, Thomas Walters, Lee A. Denson

Research output: Contribution to journalArticlepeer-review

123 Citations (Scopus)
Original languageEnglish
Pages (from-to)1708-1720
Number of pages13
JournalThe Lancet
Volume393
Issue number10182
DOIs
Publication statusPublished - Apr 27 2019
Externally publishedYes

ASJC Scopus Subject Areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study'. Together they form a unique fingerprint.

Cite this